VFEND

Product NDC: 0049-3180
11-digit product format: 000493180
Labeler code: 0049
Product ID: 0049-3180_cf9f1b2e-eeb4-48bb-9f1a-c2b8d94dfbea
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: voriconazole
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Roerig
Application: NDA021266
Marketing category: NDA
Marketing start: 2003-03-28
Marketing end: 2027-04-30
Substance: VORICONAZOLE
Active strength: 200 mg/1
Pharmacologic classes: Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]
NDC exclude flag: No
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021266-001	VFEND	VORICONAZOLE	50MG	TABLET / ORAL	AB	RLD	2002-05-24
N021266-002	VFEND	VORICONAZOLE	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N021266-001	AB
N021266-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021266-001	VFEND	50MG	TABLET / ORAL	AB	RLD	2002-05-24	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021266-002	VFEND	200MG	TABLET / ORAL	AB	RLD, RS	2002-05-24	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021266-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021266-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021266-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021266-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021266-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021266-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021266-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021266-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021266-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021266-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021266-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021266-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021266-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021266-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021266-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021266-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021266-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021266-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021266-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021266-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021266-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021266-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021266-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021266-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021266-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021266-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021266-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021266-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021266-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021266-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021266-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021266-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021266-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021266-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021266-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021266-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021266-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021266-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021266-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021266-002	AB	1	`782e0a99824c…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021266-001	NPP	2022-01-29	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021266-002	NPP	2022-01-29	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021266-001	NPP	2022-01-29	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021266-002	NPP	2022-01-29	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021266-001	NPP	2022-01-29	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021266-002	NPP	2022-01-29	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021266-001	NPP	2022-01-29	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021266-002	NPP	2022-01-29	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021266-001	NPP	2022-01-29	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021266-002	NPP	2022-01-29	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021266-001	NPP	2022-01-29	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021266-002	NPP	2022-01-29	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021266-001	NPP	2022-01-29	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021266-002	NPP	2022-01-29	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021266-001	NPP	2022-01-29	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021266-002	NPP	2022-01-29	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021266-001	NPP	2022-01-29	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021266-002	NPP	2022-01-29	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021266-001	NPP	2022-01-29	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021266-002	NPP	2022-01-29	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021266-001	NPP	2022-01-29	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021266-002	NPP	2022-01-29	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021266-001	NPP	2022-01-29	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021266-002	NPP	2022-01-29	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021266-001	NPP	2022-01-29	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021266-002	NPP	2022-01-29	`ea99ee380514…`
2023-01-26 05:58 UTC	2023-01	N021266-001	NPP	2022-01-29	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N021266-002	NPP	2022-01-29	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021266-001	NPP	2022-01-29	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021266-002	NPP	2022-01-29	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021266-001	NPP	2022-01-29	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N021266-002	NPP	2022-01-29	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021266-001	NPP	2022-01-29	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N021266-002	NPP	2022-01-29	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021266-001	NPP	2022-01-29	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021266-002	NPP	2022-01-29	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: VFEND

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
VORICONAZOLE	200 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
JFU09I87TR	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 8 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
349434	Internal RxNorm lookup
349435	Internal RxNorm lookup
351209	Internal RxNorm lookup
352218	Internal RxNorm lookup
352219	Internal RxNorm lookup
352220	Internal RxNorm lookup
465355	Internal RxNorm lookup
546624	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
ce3ef5cf-3087-4d92-9d94-9eb8287228db	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
1f86875f-c0c9-343f-b96c-14093866e7a9	Product name	9	20190409
591c07fa-4d24-4cb9-9efc-86997c696aa7	Product name	1	20170602

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0049-3180-30	2024-01-30	C162847	48780-1	1030e365-1802-111a-e063-dadaa90a10e2	These highlights do not include all the information needed to use VFEND safely and effectively. See full prescribing information for VFEND. VFEND ® (voriconazole) tablets, for oral use VFEND ® (voriconazole) for oral suspension VFEND ® (voriconazole) for injection, for intravenous use Initial U.S. Approval: 2002
0049-3180-30	2024-01-30	C162847	48780-1	1030e365-1802-111a-e063-dadaa90a10e2	These highlights do not include all the information needed to use VFEND safely and effectively. See full prescribing information for VFEND. VFEND ® (voriconazole) tablets, for oral use VFEND ® (voriconazole) for oral suspension VFEND ® (voriconazole) for injection, for intravenous use Initial U.S. Approval: 2002
0049-3180-30	2024-01-30	C162847	48780-1	1030e365-1802-111a-e063-dadaa90a10e2	These highlights do not include all the information needed to use VFEND safely and effectively. See full prescribing information for VFEND. VFEND ® (voriconazole) tablets, for oral use VFEND ® (voriconazole) for oral suspension VFEND ® (voriconazole) for injection, for intravenous use Initial U.S. Approval: 2002

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0049-3180-30	VFEND	30 in 1 BOTTLE	TABLET, FILM COATED	30		58

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0049-3180-30	EA - Each	0049-3180	a773553a-7d8b-4fff-b0ff-333469df2968	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
VORICONAZOLE	ACTIVE INGREDIENT	JFU09I87TR	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
VORICONAZOLE	ACTIVE MOIETY	JFU09I87TR	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
SUCROSE	INACTIVE INGREDIENT	C151H8M554	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
SULFOBUTYLETHER .BETA.-CYCLODEXTRIN	INACTIVE INGREDIENT	2PP9364507	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
TRISODIUM CITRATE DIHYDRATE	INACTIVE INGREDIENT	B22547B95K	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	27
voriconazole	ACTIVE INGREDIENT	JFU09I87TR	VFEND (VORICONAZOLE) TABLET, FILM COATED [CARDINAL HEALTH]	2
voriconazole	ACTIVE MOIETY	JFU09I87TR	VFEND (VORICONAZOLE) TABLET, FILM COATED [CARDINAL HEALTH]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	VFEND (VORICONAZOLE) TABLET, FILM COATED [CARDINAL HEALTH]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	VFEND (VORICONAZOLE) TABLET, FILM COATED [CARDINAL HEALTH]	2
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	VFEND (VORICONAZOLE) TABLET, FILM COATED [CARDINAL HEALTH]	2
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	VFEND (VORICONAZOLE) TABLET, FILM COATED [CARDINAL HEALTH]	2
povidone	INACTIVE INGREDIENT	FZ989GH94E	VFEND (VORICONAZOLE) TABLET, FILM COATED [CARDINAL HEALTH]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	VFEND (VORICONAZOLE) TABLET, FILM COATED [CARDINAL HEALTH]	2
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	VFEND (VORICONAZOLE) TABLET, FILM COATED [CARDINAL HEALTH]	2
triacetin	INACTIVE INGREDIENT	XHX3C3X673	VFEND (VORICONAZOLE) TABLET, FILM COATED [CARDINAL HEALTH]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0049-3180	VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]	54	Current NDC, Legacy NDC, 1 package rows	20250323_ce3ef5cf-3087-4d92-9d94-9eb8287228db.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
VFEND	VORICONAZOLE	Roerig	ce3ef5cf-3087-4d92-9d94-9eb8287228db	2026-02-26	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021266 application number: NDA021266 ndc (product): 0049-3180

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
JFU09I87TR	VORICONAZOLE	137234-62-9	VORICONAZOLE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
352220	Vfend 200 MG Injection	PSN	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
352219	Vfend 200 MG Oral Tablet	PSN	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
546624	Vfend 40 MG in 1 mL Oral Suspension	PSN	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
352218	Vfend 50 MG Oral Tablet	PSN	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
351209	voriconazole 200 MG Injection	PSN	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
349434	voriconazole 200 MG Oral Tablet	PSN	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
465355	voriconazole 40 MG in 1 mL Oral Suspension	PSN	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
349435	voriconazole 50 MG Oral Tablet	PSN	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
352220	voriconazole 200 MG Injection [Vfend]	SBD	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
352219	voriconazole 200 MG Oral Tablet [Vfend]	SBD	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
546624	voriconazole 40 MG/ML Oral Suspension [Vfend]	SBD	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
352218	voriconazole 50 MG Oral Tablet [Vfend]	SBD	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
351209	voriconazole 200 MG Injection	SCD	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
349434	voriconazole 200 MG Oral Tablet	SCD	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
465355	voriconazole 40 MG/ML Oral Suspension	SCD	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
349435	voriconazole 50 MG Oral Tablet	SCD	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
352220	Vfend 200 MG Injection	SY	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
352219	Vfend 200 MG Oral Tablet	SY	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
546624	Vfend 200 MG per 5 ML Oral Suspension	SY	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
546624	Vfend 40 MG per 1 ML Oral Suspension	SY	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
546624	Vfend 40 MG/ML Oral Suspension	SY	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
352218	Vfend 50 MG Oral Tablet	SY	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
465355	voriconazole 200 MG/5 ML Oral Suspension	SY	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58
465355	voriconazole 40 MG per 1 ML Oral Suspension	SY	ce3ef5cf-3087-4d92-9d94-9eb8287228db	58

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0049-3180-30	00049318030	30 TABLET, FILM COATED in 1 BOTTLE (0049-3180-30)	2003-03-28	2027-04-30	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
VFEND	Roerig \| Pfizer Inc \| Patheon Manufacturing Services LLC \| Fareva Amboise \| Pfizer Italia S.r.l. \| Pharmacia & Upjohn Company LLC \| Pfizer Ireland Pharmaceuticals Unlimited Company \| Upjohn Manufacturing Ireland Unlimited Company	2026-02-26	HUMAN PRESCRIPTION DRUG LABEL	58
VFEND ® I.V. (voriconazole) for Injection VFEND ® Tablets (voriconazole) VFEND ® (voriconazole) for Oral Suspension	Cardinal Health	2017-10-20	HUMAN PRESCRIPTION DRUG LABEL	3